Pharmacological agents acting at subtypes of metabotropic glutamate receptors

Neuropharmacology

Volumn 38, Issue 10, 1999, Pages 1431-1476

  Schoepp, Darryle D ^a   Jane, David E ^b   Monn, James A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Excitatory amino acid; Glutamate; Metabotropic; mGlu receptors; Pharmacology

Indexed keywords

2 AMINO 2 (2 CARBOXYPROPAN 1 YL) 3 (DIBENZOPYRAN 4 YL)PROPANOIC ACID; 2 AMINO 2 (4 CARBOXYPHENYL) 3 (9 THIOXANTHYL)PROPIONIC ACID; 2 METHYL 6 (2 PHENYLVINYL)PYRIDINE; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; CYCLOBUTANE DERIVATIVE; DICARBOXYLIC ACID DERIVATIVE; EGLUMETAD; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID DERIVATIVE; LY 393675; METABOTROPIC RECEPTOR; QUISQUALIC ACID; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

COMPETITIVE INHIBITION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0032834028     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00092-1     Document Type: Article

References (270)

1. 2+ signal transduction. Journal of Biological Chemistry. 267:1992;13361-13368.
2. Acher F.C., Tellier F.J., Azerad R., Brabet I.N., Fagni L., Pin J.-P. Synthesis and pharmacological characterisation of aminocyclopentanetricarboxylic acids: New tools to discriminate between metabotropic glutamate receptor subtypes. Journal of Medicinal Chemistry. 40:1997;3119-3129.
3. Ahmadian H., Nielsen B., Bräuner-Osborne H., Johansen T.N., Stensbøl T.B., Sløk F.A., Sekiyama N., Nakanishi S., Krogsgaard-Larsen P., Madsen U. (S)-Homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors. Journal of Medicinal Chemistry. 40:1997;3700-3705.
4. 2+ from internal stores in astroglia. Brain Research. 516:1990;165-169.
5. 35S]-GTPγS binding. British Journal of Pharmacology. 121:1997;1203-1209.
6. Albani-Torregrossa S., Pellicciari R., Moroni F., Pellegrini-Giampietro D.E. Metabotropic glutamate receptors coupled to phospholipase D. Moroni F., Nicoletti F., Pellegrini-Giampietro D.E. Metabotropic glutamate receptors and brain function. 1998;251-260 Portland Press Ltd, London.
7. Albani-Torregrossa S., Attucci S., Marinozzi M., Pellicciari R., Moroni F., Pellegrini-Giampietro D.E. Antagonist pharmacology of metabotropic glutamate receptors coupled to phospholipase D activation in adult rat hippocampus: focus on (2R,1′S,2′R,3′S)-2-(2′-carboxy-3′- phenylcyclopropyl)glycine versus 3,5-dihydroxyphenylglycine. Molecular Pharmacology. 4:1999;699-707.
8. Annoura H., Fukunaga A., Uesugi M., Tatsuoka T., Horikawa Y. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates. Bioorganic Medical Chemistry Letters. 6:1996;763-766.
9. Baker S.R., Goldsworthy J., Harden R.C., Salhoff C.R., Schoepp D.D. Enzymatic resolution and pharmacological activity of the enantiomers of 3,5-dihydroxyphenylglycine, a metabotropic glutamate receptor agonist. Bioorganic Medical Chemistry Letters. 5:1995;223-228.
10. Baker S.R., Clark B.P., Harris J.R., Griffy K.I., Kingston A.E., Tizzano J.P. LY393675, an α-substituted-cyclobutylglycine, is a potent group I metabotropic glutamate receptor antagonist. Society of Neuroscience Abstracts. 24:1998;576.
11. Bardsley M.E., Roberts P.J. Stimulation of phosphatidylinositol turnover in rat brain by glutamate and aspartate. British Journal of Pharmacology. 79:1983;401.
12. Battaglia G., Monn J.A., Schoepp D.D. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740. Neuroscience Letters. 229:1997;161-164.
13. Berridge M.J., Downes C.P., Hanley M.R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochemistry Journal. 206:1982;587-595.
14. Berridge M.J., Irvine R.F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 312:1984;315-321.
15. Birse E.F., Mewett K.N., Pook P.C.-K., Tyrell K., Udvarhelyi P.M., Wharton B., Watkins J.C. Enantiomer-specific depressant actions of 4-carboxy-3-hydroxyphenylglycine on synaptic excitation of motoneurones in newborn rat spinal cord. Journal of Physiology (Lond.). 452:1992;185P.
16. Birse E.F., Eaton S.A., Jane D.E., Jones P.L.S.T.J., Porter R.H.P., Pook P.C.-K., Sunter D.C., Udvarhelyi P.M., Wharton B., Roberts P.J., Salt T.E., Watkins J.C. Phenylglycine derivatives as new pharmacological tools for investigating the role of metabotropic glutamate receptors in the central nervous system. Neuroscience. 52:1993;481-488.
17. Boss V., Conn P.J. Metabotropic excitatory amino acid receptor activation stimulates phospholipase D in hippocampal slices. Journal of Neurochemistry. 59:1992;2340-2343.
18. Boss V., Nutt K.M., Conn P.J. L-Cysteine sulfinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity. Molecular Pharmacology. 45:1994;1177-1182.
19. Bowes, M., Panesar, M., Gentry, C., Urban, L., Gasparini, F., Kuhn, R., Walker, K., 1999. Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, methylphenylethynylpyridine, in rat models of inflammatory pain. British Journal of Pharmacology (in press).
20. Boyd E.A., Alexander S.P.H., Kendall D.A., Loh V.M. Jr. DHPMP: a novel group I specific metabotropic glutamate receptor agonist. Bioorganic Medical Chemistry Letters. 6:1996;2137-2140.
21. Brabet I., Mary S., Bockaert J., Pin J.-P. Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses. Neuropharmacology. 34:1995;895-903.
22. Brabet I., Parmentier M.-L., De Colle C., Bockaert J., Acher F., Pin J.-P. Comparative effect of L-CCG-I, DCG-IV and γ-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes. Neuropharmacology. 37:1998;1043-1051.
23. Bräuner-Osborne H., Sløk F.A., Skjærbaek N., Ebert B., Sekiyama N., Nakanishi S., Krogsgaard-Larsen P. A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid. Journal of Medicinal Chemistry. 39:1996;3188-3194.
24. Bräuner-Osborne H., Nielsen B., Stensbøl T.B., Johansen T.N., Skjærbaek N., Krogsgaard-Larsen P. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors. European Journal of Pharmacology. 335:1997;R1-R3.
25. Bräuner-Osborne H., Madsen U., Mikiciuk-Olasik E., Curry K. New analogues of ACPD with selective activity for group II metabotropic glutamate receptors. European Journal of Pharmacology. 332:1997;327-331.
26. Bräuner-Osborne H., Krogsgaard-Larsen P. Pharmacology of (S)-homoquisqualic acid and (S)-2-amino-5-phosphonopentanoic acid [(S)-AP5] at cloned metabotropic glutamate receptors. British Journal of Pharmacology. 123:1998;269-274.
27. Bräuner-Osborne H., Nielsen B., Krogsgaard-Larsen P. Molecular pharmacology of homologues of ibotenic acid at cloned metabotropic glutamic acid receptors. European Journal of Pharmacology. 350:1998;311-316.
28. 2+-sensing receptor from bovine parathyroid. Nature. 366:1993;575-580.
29. Bushell T.J., Jane D.E., Tse H.-W., Watkins J.C., Davies C.H., Garthwaite J., Collingridge G.L. Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4. Neuropharmacology. 34:1995;239-241.
30. Bushell T.J., Jane D.E., Tse H.-W., Watkins J.C., Garthwaite J., Collingridge G.L. Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices. British Journal of Pharmacology. 117:1996;1457-1462.
31. Cao C.Q., Tse H.-W., Jane D.E., Evans R.H., Headley P.M. Antagonism of mGlu receptors and potentiation of EPSCs at rat spinal motoneurones in vitro. Neuropharmacology. 36:1997;313-318.
32. B antagonists potentiate dorsal root-evoked excitatory synaptic transmission at neonatal rat spinal motoneurones in vitro. Neuroscience. 78:1997;243-250.
33. Carruthers A.M., Challiss R.A.J., Mistry R., Saunders R., Thomsen C., Nahorski S.R. Enhanced type 1α metabotropic glutamate receptor-stimulated phosphoinositide signalling after pertussis toxin treatment. Molecular Pharmacology. 52:1997;406-414.
34. Cartmell J., Curtis A.R., Kemp J.A., Kendall D.A., Alexander S.P.H. Subtypes of metabotropic excitatory amino acid receptor distinguished by stereoisomers of the rigid glutamate analogue, 1-aminocyclopentane-1,3-dicarboxylate. Neuroscience Letters. 153:1993;107-110.
35. 3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. British Journal of Pharmacology. 123:1998;497-504.
36. Cartmell, J., Monn, J.A., Schoepp, D.D., 1999. The mGlu2/3 receptor agonists, LY354740 and LY379268, selectively attenuate phencyclidine versus D-amphetamine motor behaviors in rats. Journal of Pharmacology and Experimental Therapeutics (in press).
37. Chung D.S., Traynelis S.F., Murphy T.J., Conn P.J. 4-Methylhomoibotenic acid activates a novel metabotropic glutamate receptor coupled to phosphoinositide hydrolysis. Journal of Pharmacology. 283:1997;742-749.
38. Clark B.P., Baker S.R., Goldsworthy J., Harris J.R., Kingston A.E. 2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorganic Medical Chemistry Letters. 7:1997;2777-2780.
39. Clark, B.P., Harris, J.R, Kingston, A.E., McManus, D., 1998. α-Substituted phenylglycines as group I metabotropic glutamate receptor antagonists. Poster communication at the XVth European International Symposium on Medicinal Chemistry, Edinburgh 6-10th September 1998.
40. Collado I., Ezquerra J., Mazon A., Pedregal C., Yruretagoyena B., Kingston A.E., Tomlinson R., Wright R.A., Johnson B.G., Schoepp D.D. 2,3′-disubstituted-2-(2′-carboxycyclopropyl)glycines as potent and selective antagonists of metabotropic glutamate receptors. Bioorganic Medical Chemistry Letters. 8:1998;2849-2854.
41. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Annual Reviews in Pharmacology and Toxicology. 37:1997;205-237.
42. Constantino G., Pellicciari R. Homology modelling of metabotropic glutamate receptors (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists. Journal of Medicinal Chemistry. 39:1996;3998-4006.
43. Copani S.F., Bruno V., Knöpfel T., Meltzger G., Nicoletti F. Metabotropic glutamate receptor agonists stimulate polyphosphoinositide hydrolysis in primary cultures of rat hepatocytes. European Journal of Pharmacology. 338:1997;R1-R2.
44. Corti C., Restituito S., Rimland J.M., Brabet I., Corsi M., Pin J.-P., Ferragutti F. Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8. European Journal of Neuroscience. 10:1998;3629-3641.
45. 3H]APB binding. Journal of Medicinal Chemistry. 29:1986;1988-1995.
46. Curry K., Peet M.J., Magnuson D.S.K., McLennan H. Synthesis, resolution and absolute configuration of the isomers of the neuronal excitant 1-amino-1,3-cyclopentanedicarboxylic acid. Journal of Medicinal Chemistry. 31:1988;864-867.
47. Daggett L.P., Sacaan A.I., Akong M., Rao S.P., Hess S.D., Liaw C., Urrutia A., Jachec C., Ellis S.B., Dreesen J., Knöpfel T., Landwehrmeyer G.B., Testa C.M., Young A.B., Varney M., Johnson E.C., Velicelebi G. Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5. Neuropharmacology. 34:1995;871-886.
48. Desai M.A., Conn P.J. Selective activation of phosphoinositide hydrolysis by a rigid analogue of glutamate. Neuroscience Letters. 109:1990;157-162.
49. Desai M.A., Burnett J.P., Mayne N.G., Schoepp D.D. Cloning and expression of a human metabotropic glutamate receptor 1α: enhanced coupling on co-transfection with a glutamate transporter. Molecular Pharmacology. 48:1995;648-657.
50. Desai M.A., Burnett J.P., Mayne N.G., Schoepp D.D. Pharmacological characterization of desensitization in a human mGluR1a expressing non-neuronal cell line co-transfected with a glutamate transporter. British Journal of Pharmacology. 118:1996;1558-1564.
51. Doherty A.J., Collingridge G.L., Jane D.E. Antagonist activity of α-substituted 4-carboxyphenylglycine analogues at group I metabotropic glutamate receptors expressed in CHO cells. British Journal of Pharmacology. 126:1999;205-210.
52. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 36:1997;265-267.
53. Duvoisin R.M., Zhang C., Ramonell K. A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. Journal of Neuroscience. 15:1995;3075-3083.
54. Eaton S.A., Jane D.E., Jones P.L.St.J., Porter R.H.P., Pook P.C.-K., Sunter D.C., Udvarhelyi P.M., Roberts P.J., Salt T.E., Watkins J.C. Competitive antagonism at metabotropic glutamate receptors by (S)-4-carboxyphenylglycine and (RS)-α-methyl-4-carboxyphenylglycine. European Journal of Pharmacology - Molecular Pharmacology. 244:1993;195-197.
55. Eccles J.C., McGeer P.L. Ionotropic and metabotropic neurotransmission. Trends in Neuroscience. 2:1979;39-40.
56. Emile L., Mercken L., Apiou F., Pradier L., Bock M.-D., Menager J., Clot J., Doble A., Blanchard J.-C. Molecular cloning, functional expression, pharmacological characterization and chromosomal localization of the human metabotropic glutamate receptor type 3. Neuropharmacology. 35:1996;523-530.
57. 3H]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a. British Journal of Pharmacology. 116:1995;3279-3287.
58. Escribano A., Ezquerra J., Pedregal C., Rubio A., Yruretagoyena B., Baker S.R., Wright R.A., Johnson B.G., Schoepp D.D. (2S,4S)-2-Amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonist. Bioorganic Medical Chemistry Letters. 8:1998;765-770.
59. 2+ receptor; Effects on cell surface expression, dimerization and signal transduction. FEBS Letters. 436:1998;353-356.
60. Favaron M., Manev R.M., Candeo P., Arban R., Gabellini N., Kozikowski A.P., Manev H. Trans-azetidine-2,4-dicarboxylic acid activates neuronal metabotropic receptors. NeuroReport. 4:1993;967-970.
61. Fitzjohn S.M., Bortolotto Z.A., Palmer M.J., Doherty A.J., Ornstein P.L., Schoepp D.D., Kingston A.E., Lodge D., Collingridge G.L. The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity. Neuropharmacology. 37:1998;1445-1458.
62. Flor P.J., Lindauer K., Puttner I., Ruegg D., Lukic S., Knöpfel T., Kuhn R. Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2. European Journal of Neuroscience. 7:1995;622-629.
63. Flor P.J., Lukic S., Rüegg D., Leonhardt T., Knöpfel T., Kuhn R. Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 4. Neuropharmacology. 34:1995;149-155.
64. Flor P.J., Gomeza J., Tones M.A., Kuhn R., Pin J.-P., Knöpfel T. The C-terminal domain of the mGluR1 metabotropic glutamate receptor affects sensitivity to agonists. Journal of Neurochemistry. 67:1996;58-63.
65. Flor P.J., Van Der Putten H., Rüegg D., Lukic S., Leonhardt T., Bence M., Sansig G., Knöpfel T., Kuhn R. A novel splice variant of a metabotropic glutamate receptor, human mGluR7b. Neuropharmacology. 36:1997;153-159.
66. Flor P.J., Bruno V., Battaglia G., Reutlinger S., Lukic S., Leonhardt T., Laurie D., Sommer B., Varney M., Velicelebi G., Kuhn R., Urwyler S., Dreesen J., Portet C., Schmutz M., Nicoletti F., Gasparini F. Neuroprotection in vitro and in vivo by (R,S)-PPG, a potent and selective group III metabotropic glutamate receptor agonist. Society of Neuroscience Abstracts. 24:1998;1089.
67. Gasparini F., Litschig S., Munier N., Flor P.J., Bischoff S., Vranesic I.-T., Kuhn R. CPCCOEt, a potent and selective human mGluR1b antagonist acts at a novel pharmacological site. Society of Neuroscience Abstracts. 24:1998;1344.
68. Gasparini, F., Lingenhoehl, K., Flor, P.J., Munier, N., Heinrich, M., Vranesic, I., Biollaz, M., Heckendorn, R., Allgeier, H, Varney, M., Johnson, E., Hess, S.D., Veliçelebi, G., Kuhn, R., 1999. Methylphenylethynylpyridine (MPEP): a novel potent, subtype-selective and systemically active antagonist at metabotropic glutamate receptor subtype 5. British Journal of Pharmacology (in press).
69. R)-2-(2,3-Dicarboxycyclopropyl)glycine positively modulates metabotropic glutamate receptors coupled to polyphosphoinositide hydrolysis in rat hippocampal slices. Brain Research. 659:1994;10-16.
70. Gereau R.W., Conn J.P. Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability. Journal of Neurophysiology. 74:1995;122-129.
71. Gomeza J., Joly C., Kuhn R., Knöpfel T., Bockaert J., Pin J.-P. The second intracellular loop of metabotropic glutamate receptor 1 cooperates with the other intracellular domains to control coupling to G-proteins. Journal of Biological Chemistry. 271:1996;2199-2205.
72. Gomeza J., Mary S., Brabet I., Parmentier M.-L., Restituito S., Bockaert J., Pin J.-P. Coupling of metabotropic glutamate receptors 2 and 4 to Gα15, Gα16, and chimeric Gαq/i proteins: characterization of new antagonists. Molecular Pharmacology. 50:1996;923-930.
73. Hall J.G., Hicks T.P., McLennan H., Richardson T.L., Wheal H.V. The excitation of mammalian central neurones by amino acids. Journal of Physiology. 286:1979;29-39.
74. 2+ receptors. Molecular Pharmacology. 77:1999;642-648.
75. Han G., Hampson D.R. Ligand binding of the amino-terminal domain of the mGluR4 subtype of metabotropic glutamate receptor. Journal of Biological Chemistry. 274:1999;10008-10013.
76. Hashimoto T., Inazawa J., Okamoto N., Tagawa Y., Bessho Y., Honda Y., Nakanishi S. The whole nucleotide sequence and chromosomal localization of the gene for human metabotropic glutamate receptor subtype 6. European Journal of Neuroscience. 9:1997;1226-1235.
77. Hayashi Y., Tanabe Y., Aramori I., Masu M., Shimamoto K., Ohfune Y., Nakanishi S. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. British Journal of Pharmacology. 107:1992;539-543.
78. Hayashi Y., Momiyama A., Takahashi T., Ohishi H., Ogawa-Meguro R., Shigemoto R., Mizuno N., Nakanishi S. Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb. Nature. 366:1993;687-690.
79. Hayashi Y., Sekiyama N., Nakanishi S., Jane D.E., Sunter D.C., Birse E.F., Udvarhelyi P.M., Watkins J.C. Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor sub-types. Journal of Neuroscience. 14:1994;3370-3377.
80. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. LY354740: A potent, orally active, highly selective metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal. Neuropharmacology. 36:1997;1511-1516.
81. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. Anxiolytic and side-effect profile of LY354740: A potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. Journal of Pharmacology and Experimental Therapeutics. 284:1998;651-660.
82. Hermans E., Nahorski S.R., Chaliss R.A.J. Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1a metabotropic glutamate receptor. Neuropharmacology. 37:1998;1645-1647.
83. Hermans E., Chaliss R.A.J., Nahorski S.R. Effects of varying the expression level of recombinant human mGlu1a receptors on the pharmacological properties of agonists and antagonists. British Journal of Pharmacology. 126:1999;873-882.
84. Holler T., Cappel E., Klein J., Loffelholz K. Glutamate activates phospholipase D in hippocampal slices of newborn and adult rats. Journal of Neurochemistry. 61:1993;1569-1572.
85. Holzwarth J.A., Gibbons S.J., Brorson J.R., Philipson L.H., Miller R.J. Glutamate receptor agonists stimulate diverse calcium responses in different types of cultured rat cortical glial cells. Journal of Neuroscience. 14:1993;1879-1891.
86. Houamed K.M., Kuijper J.L., Gilbert T.L., Haldeman B.A., O'Hara P.J., Mulvihill E.R., Almers W., Hagen F.S. Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from the rat brain. Science. 252:1991;1318-1321.
87. 2+ mobilization in rat cerebellar neurons. European Journal of Pharmacology. 186:1990;363-365.
88. Ishida M., Akagi H., Shimamoto K., Ohfune Y., Shinozaki H. A potent metabotropic glutamate receptor agonist: electrophysiological actions of a conformationally restricted glutamate analogue in the rat spinal cord and Xenopus oocytes. Brain Research. 537:1990;311-314.
89. Ishida M., Saitoh T., Shimamoto K., Ohfune Y., Shinozaki H. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. British Journal of Pharmacology. 109:1993;1169-1177.
90. Ishida M., Saitoh T., Nakamura Y., Kataoka K., Shinozaki H. A novel metabotropic glutamate receptor agonist: (2S,1′S,2′R,3′R)-2-(2-carboxy-3-methoxymethylcyclopropyl) glycine (cis-MCG-I). European Journal of Pharmacology - Molecular Pharmacology Section. 268:1994;267-270.
91. Ishida M., Saitoh T., Tsuji K., Nakamura Y., Kataoka K., Shinozaki H. Novel agonists for metabotropic glutamate receptors: trans- and cis-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine (trans- and cis-MCG-I). Neuropharmacology. 34:1995;821-827.
92. Ito I., Kohda A., Tanabe S., Hirose E., Hayashi M., Mitsunaga S., Sugiyama H. 3,5-Dihydroxyphenylglycine: a potent agonist of metabotropic glutamate receptors. NeuroReport. 3:1992;1013-1016.
93. Jane D.E., Jones P.L.St.J., Pook P.C.-K., Salt T.E., Sunter D.C., Watkins J.C. Stereospecific antagonism by (+)-α-methyl-4-carboxyphenylglycine (MCPG) of (1S,3R)-ACPD-induced effects in neonatal rat motoneurones and rat thalamic neurones. Neuropharmacology. 32:1993;725-727.
94. Jane D.E., Jones P.L.St.J., Pook P.C.-K., Tse H.-W., Watkins J.C. Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord. British Journal of Pharmacology. 112:1994;809-816.
95. Jane D.E., Pittaway K., Sunter D.C., Thomas N.K., Watkins J.C. New phenylglycine derivatives with potent and selective antagonist activity at presynaptic glutamate receptors in neonatal rat spinal cord. Neuropharmacology. 34:1995;851-856.
96. Jane D.E., Thomas N.K., Tse H.-W., Watkins J.C. Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neuropharmacology. 35:1996;1029-1035.
97. Jane D.E., Pittaway K., Sunter D.C., Thomas N.K., Tse H.-W. Phosphono substituted amino acids as selective metabotropic glutamate receptor antagonists. Phosphorus, Sulphur, Silicon and Related Elements. 109-110:1996;313-316.
98. Johansen P.A., Chase L.A., Sinor A.D., Koerner J.F., Johnson R.L., Robinson M.B. Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats. Molecular Pharmacology. 48:1995;140-149.
99. Johansen P.A., Robinson M.B. Identification of 2-amino-2-methyl-4-phosphonobutanoic acid as an antagonist at the mGlu(4a) receptor. European Journal of Pharmacology - Molecular Pharmacology. 290:1995;R1-R3.
100. 3H]-LY341495 as a novel rapid filtration antagonist radioligand for group II metabotropic glutamate receptors: Characterization of binding to membranes of mGlu receptor subtype expressing cells. Neuropharmacology 38, 1519-1529.
101. Joly C., Gomeza J., Brabet I., Curry K., Bockaert J., Pin J.-P. Molecular, functional and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. Journal of Neuroscience. 15:1995;3970-3981.
102. B receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386:1997;239-246.
103. Kemp M.C., Roberts P.J., Pook P.C.-K., Jane D.E., Jones A.W., Jones P.L.St.J., Sunter D.C., Udvarhelyi P.M., Watkins J.C. Antagonism of presynaptically mediated depressant responses and cyclic AMP-coupled metabotropic glutamate receptors. European Journal of Pharmacology - Molecular Pharmacology. 266:1994;187-192.
104. Kemp M.C., Jane D.E., Tse H.-W., Roberts P.J., Watkins J.C. Antagonist effects of 3-carboxy derivatives of phenylglycine and phenylalanine mGluR ligands on cortical adenylyl cyclase activity. British Journal of Pharmacology Proceedings Supplement. 113:1994;147P.
105. Kemp M.C., Jane D.E., Tse H.-W., Roberts P.J., Watkins J.C. mGluRs negatively coupled to adenylyl cyclase are potently antagonised by novel phosphono- and sulphono- but not tetrazolyl-substituted phenylglycine derivatives. British Journal of Pharmacology Proceedings Supplement. 116:1995;108P.
106. Kemp M.C., Jane D.E., Tse H.-W., Roberts P.J. Agonists of cyclic AMP-coupled metabotropic glutamate receptors in adult-rat cortical slices. European Journal of Pharmacology. 309:1996;79-85.
107. Kemp M.C., Jane D.E., Tse H.-W., Roberts P.J. α-Methyl-3-phosphonophenylalanine and α-cyclopropyl-4-phosphonophenylglycine are potent antagonists at mGluRs negatively coupled to adenylyl cyclase. British Journal of Pharmacology Proceedings Supplement. 117:1996;334P.
108. Kilbride J., Huang L.-Q., Rowan M.J., Anwyl R. Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV. European Journal of Pharmacology. 356:1998;149-157.
109. Kingston A.E., Burnett J.P., Mayne N.G., Lodge D. Pharmacological analysis of 4-carboxyphenylglycine derivatives: comparison of effects on mGluR1α and mGluR5a subtypes. Neuropharmacology. 34:1995;887-894.
110. Kingston A.E., Lowndes J., Evans N., Clark B., Tomlinson R., Burnett J.P., Mayne N.G., Cockerham S.L., Lodge D. Sulfur-containing amino acids are agonists for group 1 metabotropic receptors expressed in clonal RGT cell lines. Neuropharmacology. 37:1998;277-287.
111. Kingston A.E., Ornstein P.L., Wright R.A., Johnson B.G., Mayne N.G., Burnett J.P., Belagaje R., Wu S., Schoepp D.D. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology. 37:1998;1-12.
112. Klein J., Iovino M., Vakil M., Shinozaki H., Loffelholz K. Ontogenic and pharmacological studies on metabotropic glutamate receptors coupled to phospholipase D activation. Neuropharmacology. 36:1997;305-311.
113. Knöpfel T., Lukic S., Leonardt T., Flor P.J., Kuhn R., Gasparini F. Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology. 34:1995;1099-1102.
114. Knöpfel T., Kuhn R., Allgeier H. Metabotropic glutamate receptors: Novel targets for drug development. Journal of Medicinal Chemistry. 38:1995;1417-1426.
115. Knöpfel T., Sakaki J., Flor P.J., Baumann P., Sacaan A.I., Veliçelebi G., Kuhn R., Allgeier H. Profiling of trans-azetidine-2,4-dicarboxylic acid at the human metabotropic glutamate receptors mGlu1b, -2,-4a and -5a. European Journal of Pharmacology. 288:1995;389-392.
116. Koerner J.F., Cotman C.W. Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex. Brain Research. 216:1981;192-198.
117. 35S]GTPγS binding assays. Society of Neuroscience Abstracts. 24:1998;576.
118. Kozikowski A.P., Liao Y., Tückmantel W., Wang S., Pshenichkin S., Surin A., Thomsen C., Wroblewski J.T. Synthesis and biology of the rigidified glutamate analogue, trans-2-carboxyazetidine-3-acetic acid (t-CAA). Bioorganic Medical Chemistry Letters. 6:1996;2559-2564.
119. Kozikowski A.P., Araldi G.L., Flippen-Anderson J., George C., Pshenichkin S., Surina E., Wroblewski J. Synthesis and metabotropic glutamate receptor activity of a 2-aminobicyclo[3.2.0]heptane-2,5-dicarboxylic acid, a molecule possessing an extended glutamate conformation. Bioorganic Medical Chemistry Letters. 8:1998;925-930.
120. Kozikowski A.P., Steensma D., Luca-Araldi G., Tückmantel W., Wang S., Pshenichkin S., Surina E., Wroblewski J.T. Synthesis and biology of the conformationally restricted ACPD analog, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist. Journal of Medicinal Chemistry. 41:1998;1641-1650.
121. Kozikowski A.P., Steensma D., Varasi M., Pshenichkin S., Surina E., Wroblewski J.T. Substituted quisqualic acid analogs: new metabotropic glutamate receptor group II selective antagonists. Bioorganic Medical Chemistry Letters. 8:1998;447-452.
122. Kristensen P., Suzdak P.D., Thomsen C. Expression pattern and pharmacology of the rat type IV metabotropic glutamate receptor. Neuroscience Letters. 155:1993;159-162.
123. Kroona H.B., Peterson N.L., Koerner J.F., Johnson R.L. Synthesis of the 2-amino-4-phosphonobutanoic acid analogues (E)- and (Z)-2-amino-2,3-methano-4-phosphonobutanoic acid and their evaluation as inhibitors of hippocampal excitatory neurotransmission. Journal of Medicinal Chemistry. 34:1991;1692-1699.
124. 2+-sensing function of the metabotropic glutamate receptors. Science. 279:1998;1722-1725.
125. Kubokawa K., Miyashita T., Nagasawa H., Kubo Y. Cloning and characterization of a bifunctional metabotropic receptor activated by both extracellular calcium and glutamate. FEBS Letters. 392:1996;71-76.
126. B receptor function. Science. 283:1999;74-77.
127. Laurie D.J., Danzeisen M., Boddeke H.W.G.M., Sommer B. Ligand binding profile of the rat metabotropic glutamate receptor mGluR3 expressed in a transfected cell line. Naunyn-Schmiedeberg's Archives in Pharmacology. 351:1995;565-568.
128. 1d, a novel splice variant of the human type I metabotropic glutamate receptor. European Journal of Pharmacology. 296:1996;R1-R3.
129. 6 metabotropic glutamate receptor. Neuropharmacology. 36:1997;145-152.
130. Lin F.F., Varney M., Sacaan A.I., Jachec C., Daggett L.P., Rao S., Flor P., Kuhn R., Kerner J.A., Standaert D., Young A.B., Velicelebi G. Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype. Neuropharmacology. 36:1997;917-931.
131. Littman L., Chase L.A., Renzi M., Garlin A.B., Koerner J.F., Johnson R.L., Robinson M.B. Effects of quisqualic acid analogs on metabotropic glutamate receptors coupled to phosphoinositide hydrolysis in rat hippocampus. Neuropharmacology. 34:1995;829-841.
132. Littman L., Tokar C., Venkatraman S., Roon R.J., Koerner J.F., Robinson M.B., Johnson R.L. Cyclobutane quisqualic acid analogues as selective mGluR5a metabotropic glutamic acid receptor ligands. Journal of Medicinal Chemistry. 42:1999;1639-1647.
133. Litschig S., Gasparini F., Rueegg D., Stoehr N., Flor P.J., Vranesic I., Prezeau L., Pin J.-P., Thomsen C., Kuhn R. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding. Molecular Pharmacology. 55:1999;453-461.
134. 3H]-aspartate output in rat striatum. British Journal of Pharmacology. 110:1993;1407-1412.
135. Ma D., Tian H., Sun H., Kozikowski A.P., Pschenichkin S., Wroblewski J.T. Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists. Bioorganic Medical Chemistry Letters. 9:1997;1195-1198.
136. Ma D., Ma Z., Kozikowski A.P., Pschenichkin S., Wroblewski J.T. Synthesis and biological evaluation of two analogues of (S)-α-methyl-3-carboxyphenylalanine. Bioorganic Medical Chemistry Letters. 9:1998;1195-1198.
137. Makoff A., Lelchuk R., Oxer M., Harrington K., Emson P. Molecular characterization and localization of human metabotropic glutamate receptor type 4. Molecular Brain Research. 37:1996;239-248.
138. Makoff A., Volpe F., Lelchuk R., Harrington K., Emson P. Molecular characterization and localization of human metabotropic glutamate receptor type 3. Molecular Brain Research. 40:1996;55-63.
139. Makoff A., Pilling C., Harrington K., Emson P. Human metabotropic glutamate receptor type 7: molecular cloning and mRNA distribution in the CNS. Molecular Brain Research. 40:1996;165-170.
140. Malherbe P., Kratzeisen C., Lundstrom K., Richards J.G., Faull R.L.M., Mutel V. Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. Molecular Brain Research. 67:1999;201-210.
141. Manzoni O., Fagni L., Pin J.-P., Rassendren F., Poulat F., Sladeczek F., Bockaert J. (trans)-1-Amino-cyclopentyl-1,3-dicarboxylate stimulates quisqualate phosphoinositide-coupled receptors but not ionotropic glutamate receptors in striatal neurons and Xenopus oocytes. Molecular Pharmacology. 38:1990;1-6.
142. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760-765.
143. McGeer P.L., Eccles J.C., McGeer E.G. Molecular Biology of the Mammalian Brain. 1978;Plenum Press, New York.
144. McLennan H., Curry K. The actions of cyclopentane analgues of glutamic acid at binding sites for kainic and glutamic acids. Experimental Brain Research. 72:1988;436-438.
145. Minakami R., Katsuki F., Sugiyama H. A variant of metabotropic glutamate receptor subtype 5: an evolutionally conserved insertion with no termination codon. Biochemical and Biophysical Research Communications. 194:1993;622-627.
146. Minakami R., Katsuki F., Yamamoto T., Nakamura K., Sugiyama H. Molecular cloning and the functional expression of two isoforms of human metabotropic glutamate receptor subtype 5. Biochemical and Biophysical Research Communications. 199:1994;1136-1143.
147. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349-1352.
148. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annual Reviews in Pharmacology and Toxicology. 29:1989;365-402.
149. Monn J.A., Valli M.J., Johnson B.G., Salhoff C.R., Wright R.A., Howe T., Bond A., Lodge D., Spangle L.A., Paschal J.W., Campbell J.B., Griffey K., Tizzano J.P., Schoepp D.D. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase. Journal of Medicinal Chemistry. 39:1996;2990-3000.
150. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): a potent, selective and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. Journal of Medicinal Chemistry. 40:1997;528-537.
151. Monn J.A., Valli M.J., Massey S.M., Hansen M.M., Kress T.J., Wepsiec J.P., Harkness A.R., Grutsch J.L. Jr., Wright R.A., Johnson B.G., Andis S.L., Kingston A.E., Tomlinson R., Lewis R., Griffey K.R., Tizzano J.P., Schoepp D.D. Synthesis, pharmacological characterization and molecular modeling of heterobicyclic amino acids related to LY354740: Identification of LY379268 and LY389795: Two new potent, selective and systemically active agonists for group II metabotropic glutamate receptors. Journal of Medicinal Chemistry. 42:1999;1027-1040.
152. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Torregrossa S.A., Pellegrini-Giampietro D.E., Luneia R., Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. Journal of Pharmacology and Experimental Therapeutics. 281:1997;721-729.
153. 2+ mobilization in hippocampal neurons. Proceedings of the National Academy of Science USA. 85:1988;8737-8741.
154. 3H]-dicarboxycyclopropyl)glycine binding in rat brain. Journal of Neurochemistry. 71:1998;2558-2564.
155. Nakagawa Y., Saitoh K., Ishihara T., Ishida M., Shinozaki H. (2S,3S,4S)-α-(Carboxycyclopropyl)glycine is a novel agonist of metabotropic glutamate receptors. European Journal of Pharmacology. 184:1990;205-206.
156. Nakajima Y., Iwakabe H., Akazawa C., Nawa H., Shigemoto R., Mizuno R., Nakanishi S. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. Journal of Biological Chemistry. 268:1993;11868-11873.
157. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
158. Nicoletti F., Casabona G., Genazzani A.A., L'Episcopo M.R., Shinozaki H. (2S,1′R,2′R,3′R)-2-(2,3-Dicarboxycyclopropyl)glycine enhances quisqualate-stimulated inositol phospholipid hydrolysis in hippocampal slices. European Journal of Pharmacology - Molecular Pharmacology Section. 245:1993;297-298.
159. Nicoletti F., Iadarola M.J., Wroblewski J.T., Costa E. Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: Developmental changes and interaction with α1-adrenoceptors. Proceedings of the National Academy of Science USA. 83:1986;1931-1935.
160. Nicoletti F., Meek J.L., Iadarola M.J., Chuang D.M., Roth B.L., Costa E. Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. Journal of Neurochemistry. 46:1986;40-46.
161. Nicoletti F., Wroblewski J.T., Novelli A., Alho H., Guidotti A., Costa E. The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. Journal of Neuroscience. 6:1986;1905-1911.
162. Nicoletti F., Bruno V., Copani A., Casabona G., Knöpfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends in Neuroscience. 19:1996;267-271.
163. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science. 225:1984;1365-1370.
164. O'Hara P.J., Sheppard P.O., Thogersen H., Venezia D., Haldeman B.A., McGrane V., Houamed K.M., Thomsen C., Gilbert T.L., Mulvihill E.R. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron. 11:1993;41-52.
165. Ohfune Y., Shimamoto K., Ishida M., Shinozaki H. Synthesis of L-2-(2,3-dicarboxycyclopropyl)glycines. Novel conformationally restricted glutamate analogues. Bioorganic Medical Chemistry Letters. 3:1993;15-18.
166. Okamoto N., Hori S., Akazawa C., Hayashi Y., Shigemoto R., Mizuno N., Nakanishi S. Molecular characterization of a new metabotropic glutamate receptor mGluR7 coupled to inhibitory cyclic AMP signal transduction. Journal of Biological Chemistry. 269:1994;1231-1236.
167. Okamoto T., Sekiyama N., Otsu M., Shimada Y., Sato A., Nakanishi S., Jingami H. Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. Journal of Biological Chemistry. 273:1998;13089-13096.
168. Ornstein P.L., Bleisch T.J., Arnold M.B., Wright R.A., Johnson B.G., Schoepp D.D. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution. Journal of Medicinal Chemistry. 41:1998;346-357.
169. Ornstein P.L., Bleisch T.J., Arnold M.B., Kennedy J.H., Wright R.A., Johnson B.G., Tizzano J.P., Helton D.R., Kallman M.J., Schoepp D.D., Hérin M. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. Journal of Medicinal Chemistry. 41:1998;358-378.
170. 3H]LY341495, a highly potent, selective and novel radioligand for labeling group II metabotropic glutamate receptors. Bioorganic Medical Chemistry Letters, 1919-1922.
171. Ozawa S., Kamiya H., Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Progress in Neurobiology. 54:1998;581-618.
172. Palmer E., Monaghan D.T., Cotman C.W. Glutamate receptors and phosphoinositide metabolism: stimulation via quisqualate receptors is inhibited by N-methyl-D-aspartate receptor activation. Molecular Brain Research. 4:1988;161-165.
173. Palmer E., Monaghan D.T., Cotman C.W. Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor. European Journal of Pharmacology. 166:1989;585-587.
174. Parmentier M.-L., Pin J.-P., Bockaert J., Grau Y. Cloning and functional expression of a Drosophila metabotropic glutamate receptor expressed in the embryonic CNS. Journal of Neuroscience. 16:1996;6687-6694.
175. Parmentier M.-L., Joly C., Restituito S., Bockaert J., Grau Y., Pin J.-P. The G protein coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain. Molecular Pharmacology. 53:1998;778-786.
176. Pearce B., Albrecht J., Morrow C., Murphy S. Astrocyte glutamate receptor activation promotes inositol phospholipid turnover and calcium flux. Neuroscience Letters. 72:1986;335-340.
177. Pellegrini-Giampietro D., Albani-Torregrossa S., Moroni F. Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus. British Journal of Pharmacology. 118:1996;1035-1043.
178. Pellicciari R., Luneia R., Constantino G., Marinozzi M., Natalini B., Jakobsen P., Kanstrup A., Lombardi G., Moroni F., Thomsen C. 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist of phospholipase C-linked metabotropic glutamate receptors. Journal of Medicinal Chemistry. 38:1995;3717-3719.
179. Pellicciari R., Marinozzi M., Natalini B., Costantino G., Luneia R., Giorgi G., Moroni F., Thomsen C. Synthesis and pharmacological characterisation of all sixteen stereoisomers of 2-(2′-carboxy-3′-phenylcyclopropyl)glycine. Focus on (2S,1′S,2′S,3′R)-2-(2′-carboxy-3′- phenylcyclopropyl)glycine, a novel and selective group II metabotropic glutamate receptor antagonist. Journal of Medicinal Chemistry. 39:1996;2259-2269.
180. Pellicciari R., Raimondo M., Marinozzi M., Natalini B., Costantino G., Thomsen C. (S)-(+)-2-(3′-Carboxybicyclo[1,1,1]pentyl)glycine, a structurally new group I metabotropic glutamate receptor antagonist. Journal of Medicinal Chemistry. 39:1996;2874-2876.
181. Pellicciari R., Costantino G., Giovagnoni E., Mattoli L., Brabet I., Pin J.-P. Synthesis and preliminary evaluation of (S)-2-(4′-carboxycubyl)glycine, a new selective mGluR1 antagonist. Bioorganic Medical Chemistry Letters. 8:1998;1569-1574.
182. Peterson N.L., Kroona H.B., Johnson R.L., Koerner J.F. Activity of the conformationally rigid 2-amino-4-phosphonobutanoic acid (AP4) analogue (RS)-1-amino-3-(phosphonomethylene)cyclobutane-1-carboxylic acid (cyclobutylene AP5) on evoked responses in the perforant pathway of rat hippocampus. Brain Research. 571:1992;162-164.
183. Pickering D.S., Thomsen C., Suzdak P.D., Fletcher E.J., Robitaille R., Salter M.W., MacDonald J.F., Huang X.-P., Hampson D.R. A comparison of two alternatively spliced forms of a metabotropic glutamate receptor coupled to phosphoinositide turnover. Journal of Neurochemistry. 61:1993;85-92.
184. Pin J.-P., Waeber C., Prezeau L., Bockaert J., Heinemann S.F. Alternative splicing generates metabotropic glutamate receptors inducing different patterns of calcium release in Xenopus oocytes. Proceedings of the National Academy of Science USA. 89:1992;10331-10335.
185. Pin J.-P., Joly C., Heinemann S.F., Bockaert J. Domains involved in the specificity of G-protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO Journal. 13:1994;342-348.
186. Pin J.-P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
187. Pin J.-P., Gomeza J., Joly C., Bockaert J. The metabotropic glutamate receptors: their second intracellular loop plays a critical role in the G-protein coupling specificity. Biochemistry Society Transactions. 23:1995;91-96.
188. Pinkney J.M., Kingston W.P., Thomas N.K., Jane D.E., Pook P.C.-K. Electrophysiological characterisation of 1-aminoindan-1,5-dicarboxylic acid on the neonatal rat spinal cord preparation. British Journal of Pharmacology Proceedings Supplement. 123:1998;17P.
189. Pook P.C.K., Sunter D.C., Udvarhelyi P.M., Watkins J.C. Evidence for pre-synaptic depression of monosynaptic excitation in neonatal rat motoneurons by (1S,3S)-ACPD and (1S,3R)-ACPD. Experimental Physiology. 77:1992;529-532.
190. Pook P.C.-K., Birse E.F., Jane D.E., Jones A.W., Jones P.L.St.J., Mewett K.N., Sunter D.C., Udvarhelyi P.M., Wharton B., Watkins J.C. Differential actions of the metabotropic glutamate receptor antagonists 4C-PG and (M4C-PG at L-AP4-like receptors in neonatal rat spinal cord. British Journal of Pharmacology Proceedings Supplement. 108:1993;87P.
191. Porter R.H.P., Roberts P.J. Glutamate metabotropic receptor activation in neonatal rat cerebral cortex by sulfur-containing excitatory amino acids. Neuroscience Letters. 154:1993;78-80.
192. Porter R.H.P., Roberts P.J., Jane D.E., Watkins J.C. (S)-Homoquisqualate: a potent agonist at the glutamate metabotropic receptor. British Journal of Pharmacology. 106:1992;509-510.
193. Recasens M., Sassetti I., Nourigat A., Sladeczek F., Bockaert J. Characterization of subtypes of excitatory amino acid receptors involved in the stimulation of inositol phosphate synthesis in rat brain synaptoneurosomes. European Journal of Pharmacology. 141:1987;87-93.
194. Recasens M., Guiramand J., Nourigat A., Sassetti I., Devilliers G. A new quisqualate receptor subtype (sAA2) responsible for the glutamate-induced inositol phosphate formation in rat brain synaptoneurosomes. Neurochemistry International. 13:1988;463-467.
195. Roberts P.J. Pharmacological tools for the investigation of metabotropic glutamate receptors (mGluRs): phenylglycine derivatives and other selective antagonists - an update. Neuropharmacology. 34:1995;813-819.
196. Romano C., Yang W.-L., O'Malley K.L. Metabotropic glutamate receptor 5 is a disulfide-linked dimer. Journal of Biological Chemistry. 271:1996;28612-28616.
197. Romano C., Saito I., O'Malley K.L. Metabotropic glutamate receptor dimers. Moroni F., Nicoletti F., Pellegrini-Giampietro D.E. Metabotropic Glutamate Receptors and Brain Function. 1998;1-6 Portland Press Ltd, London.
198. Ruat M., Molliver M.E., Snowman A.M., Synder S.H. Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proceedings of the National Academy of Science USA. 92:1995;3161-3165.
199. Sacaan A.I., Santori E.M., Rao T.S. (S)-4-Carboxy-3-hydroxyphenylglycine activates phosphatidyl inositol linked metabotropic glutamate receptors in different brain regions of the neonatal rat. Neurochemistry International. 32:1998;77-85.
200. Saitoh T., Ishida M., Shinozaki H. Potentiation by DL-α-aminopimelate of the inhibitory action of a novel mGluR agonist (L-F2CCG-I) on monosynaptic excitation in the rat spinal cord. British Journal of Pharmacology. 123:1998;771-779.
201. Salt T.E., Eaton S.A. Distinct presynaptic metabotropic receptors for L-AP4 and CCG1 on GABAergic terminals: pharmacological evidence using novel α-methyl derivative mGluR antagonists, MAP4 and MCCG, in the rat thalamus in vivo. Neuroscience. 65:1995;5-13.
202. Salt T.E., Turner J.P. Antagonism of the presumed presynaptic action of L-AP4 on GABAergic transmission in the ventrobasal thalamus by the novel mGluR antagonist MPPG. Neuropharmacology. 35:1996;239-241.
203. Salt T.E., Turner J.P. Reduction of sensory and metabotropic glutamate receptor responses in the thalamus by the novel metabotropic glutamate receptor-1-selective antagonist S-2-methyl-4-carboxy-phenylglycine. Neuroscience. 85:1998;655-658.
204. Saugstad J.A., Kinzie J.M., Mulvihill E.R., Segerson T.P., Westbrook G.L. Cloning and expression of a new member of the L-2-amino-4-phosphonobutyric acid-sensitive class of metabotropic glutamate receptors. Molecular Pharmacology. 45:1994;367-372.
205. Saugstad J.A., Segerson T.P., Westbrook G.L. L-2-amino-3-phosphonopropionic acid competitively antagonizes metabotropic glutamate receptors 1α and 5 in Xenopus oocytes. European Journal of Pharmacology - Molecular Pharmacology Section. 289:1995;395-397.
206. Saugstad J.A., Kinzie J.M., Shinohara M.M., Segerson T.P., Westbrook G.L. Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. Molecular Pharmacology. 51:1997;119-125.
207. Schaffhauser H., Cartmell J., Jakob-Rotne R., Mutel V. Pharmacological characterization of metabotropic glutamate receptors linked to the inhibition of adenylate cyclase activity in rat striatal slices. Neuropharmacology. 36:1997;933-940.
208. Scherer S.W., Soder S., Duvoisin R.M., Huizenga J.J., Tsui L.-C. The human metabotropic glutamate receptor 8 (GRM8) gene: A disportionately large gene located at 7q31.3-q32.1. Genomics. 44:1997;232-236.
209. Schoepp D.D., Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends in Pharmacol. Science. 14:1993;13-20.
210. Schoepp D.D., Hillman C.C. Developmental and pharmacological characterization of quisqualate, ibotenate, and trans-1-amino-1,3-cyclopentanedicarboxylic acid stimulations of phosphoinositide hydrolysis in rat cortical brain slices. Biogenic Amines. 7:1990;331-340.
211. Schoepp D.D., Johnson B.G. Excitatory amino acid agonist-antagonist interactions at 2-amino-4-phosphonobutyric acid-sensitive quisqualate receptors coupled to phosphoinositide hydrolysis in slices of rat hippocampus. Journal of Neurochemistry. 50:1988;1605-1613.
212. 3H]acetylaspartylglutamate binding in rat brain: Selective inhibition of phosphoinositide hydrolysis by 2-amino-3-phosphonopropionate. Journal of Neurochemistry. 53:1989;273-278.
213. Schoepp D.D., Johnson B.G. Inhibition of excitatory amino acid-stimulated phosphoinositide hydrolysis in the neonatal rat hippocampus by 2-amino-3-phosphonopropionate. Journal of Neurochemistry. 53:1989;1865-1870.
214. Schoepp D.D., Bockaert J., Sladeczek F. Pharmacological and functional characteristics of metabotropic excitatory amino acid receptors. Trends in Pharmacological Science. 11:1990;508-515.
215. Schoepp D.D., Johnson B.G., Salhoff C.R., McDonald J.W., Johnston M.V. In vitro and in vivo pharmacology of trans- and cis-(±)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. Journal of Neurochemistry. 56:1991;1789-1796.
216. Schoepp D.D., Johnson B.G., True R.A., Monn J.A. Comparison of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD)- and 1R,3S-ACPD-stimulated brain phosphoinositide hydrolysis. European Journal of Pharmacology - Molecular Pharmacology Section. 207:1991;351-353.
217. Schoepp D.D., Johnson B.G., Sacaan A.I., True R.A., Monn J.A. In vitro and in vivo pharmacology of 1S,3R- and 1R,3S-ACPD: evidence for a role of metabotropic glutamate receptors in striatal motor function. Molecular Neuropharmacology. 2:1992;33-37.
218. Schoepp D.D., Johnson B.G., Monn J.A. Inhibition of cyclic AMP formation by a selective metabotropic glutamate receptor agonist. Journal of Neurochemistry. 58:1992;1184-1186.
219. Schoepp D.D., Goldsworthy J., Johnson B.G., Salhoff C.R., Baker S.R. 3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. Journal of Neurochemistry. 63:1994;769-772.
220. Schoepp D.D., Johnson B.G., Salhoff C.R., Valli M.J., Desai M.A., Burnett J.P., Mayne N.G., Monn J.A. Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate. Neuropharmacology. 34:1995;843-850.
221. Schoepp D.D., Johnson B.G., Salhoff C.R., Wright R.A., Goldsworthy J.S., Baker S.R. Second-messenger responses in brain slices to elucidate novel glutamate receptors. Journal of Neuroscience Methods. 59:1995;105-110.
222. Schoepp D.D., Salhoff C.R., Wright R.A., Johnson B.G., Burnett J.P., Mayne N.G., Belagaje R., Wu S., Monn J.A. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors. Neuropharmacology. 35:1996;1661-1672.
223. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerham S.L., Burnett J.P., Belagaje R., Bleakman D., Monn J.A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology. 36:1997;1-11.
224. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Monn J.A. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist. Naunyn-Schmiedeberg's Archives in Pharmacology. 358:1998;175-180.
225. Sekiyama N., Hayashi Y., Nakanishi S., Jane D.E., Tse H.-W., Birse E.F., Watkins J.C. Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor sub-types. British Journal of Pharmacology. 117:1996;1493-1503.
226. Servitja J.-M., Masgrau R., Sarri E., Picatoste F. Group I metabotropic glutamate receptors mediate phospholipase D stimulation in rat cultured astrocytes. Journal of Neurochemistry. 72:1999;1441-1447.
227. Shibuya A., Sato A., Taguchi T. Preparation of difluoro analogs of CCGs and their pharmacological evaluations. Bioorganic Medical Chemistry Letters. 8:1998;1979-1984.
228. Shimamoto, K., Ohfune, Y., 1993. Inversion of cis-substituted α-cyclopropyl acyl anion. Stereoselective entry to the synthesis of a potent metabotropic glutamate agonist, (2S,1′S,2′S)-2-(carboxycyclopropyl)glycine (L-CCG-I), and its 3′-substituted analogues. SynLett., 919-920.
229. Sladeczek F., Pin J.-P., Recasens M., Bockaert J., Weiss S. Glutamate stimulates inositol phosphate formation in striatal neurones. Nature. 317:1985;717-719.
230. Stephan D., Bon C., Holzwarth J.A., Galvan M., Pruss R.M. Human metabotropic glutamate receptor 1: mRNA distribution, chromosome localization and functional expression of two splice variants. Neuropharmacology. 35:1996;1649-1660.
231. Stephani R.A., Rowe W.B., Gass J.D., Meister A. Utilization of a cyclopentane analog of glutamate (cis-1-amino-1,3-dicarboxycyclopentane) by glutamine synthetase. Biochemistry. 11:1972;4094-4100.
232. Strader C.D., Fong T.M., Tota M.R., Underwood D. Structure and function of G-protein-coupled receptors. Annual Reviews in Biochemistry. 63:1994;101-132.
233. Strader C.D., Fong T.M., Graziano M.P., Tota M.R. The family of G-protein-coupled receptors. FSAEB Journal. 9:1995;745-754.
234. Sugiyama H., Ito I., Hirono C. A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature. 325:1987;531-533.
235. Sunter D.C., Degar G.E., Pook P.C.-K., Howard J.A.K., Udvarhelyi P.M., Watkins J.C. Actions of the four isomers of 1-aminocyclopentane-1,3-dicarboxylate (ACPD) in the hemisected isolated spinal cord of the neonatal rat. British Journal of Pharmacology. 104:1991;377.
236. Takahashi K., Tsuchida K., Tanabe Y., Masu M., Nakanishi S. Role of the large extracellular domain of metabotropic glutamate receptors in agonist selectivity determination. Journal of Biological Chemistry. 268:1993;19341-19345.
237. Tanabe S., Ito I., Sugiyama H. Possible heterogeneity of metabotropic glutamate receptors induced in Xenopus oocytes by rat brain mRNA. Neuroscience Research. 10:1991;71-77.
238. Tanabe Y., Masu M., Ishii T., Shigemoto R., Nakanishi S. A family of metabotropic glutamate receptors. Neuron. 8:1992;169-179.
239. Tanabe Y., Nomura A., Masu M., Shigemoto R., Mizuno N., Nakanishi S. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. Journal of Neuroscience. 13:1993;1372-1378.
240. Thomas N.K., Gardener M.J., Jane D.E., Miller J.C. Phenylglycines as antagonists of (1S,3R)-ACPD-induced depolarizations in the neonatal rat spinal cord. Neuropharmacology. 35(A31):1996;121.
241. Thomas N.K., Jane D.E., Tse H.-W., Watkins J.C. Methyl derivatives of serine-O-phosphate as novel selective competitive metabotropic glutamate receptor antagonists. Neuropharmacology. 35:1996;637-642.
242. Thomas N.K., Woolley M.L., Miller J.C., Clark B.P., Harris J.R., Jane D.E., Watkins J.C. Novel phenylglycines as metabotropic glutamate receptor antagonists. Society of Neuroscience Abstracts. 24:1998;576.
243. Thomsen C. The L-AP4 receptor. General Pharmacology. 29:1997;151-158.
244. Thomsen C., Kristensen P., Mulvihill E., Haldeman B., Suzdak P.D. L-2-Aminno-4-phosphonobutyrate (L-AP4) is an agonist at the type IV metabotropic glutamate receptor which is negatively coupled to adenylate cyclase. European Journal of Pharmacology - . Molecular Pharmacology Section. 227:1992;361-362.
245. Thomsen C., Mulvihill E.R., Haldeman B., Pickering D.S., Hampson D.R., Suzdak P.D. A pharmacological characterization of the mGluR1α subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line. Brain Research. 619:1993;22-28.
246. Thomsen C., Hansen L., Suzdak P.D. L-Glutamate uptake inhibitors may stimulate phosphoinositide hydrolysis in baby hamster kidney cells expressing mGluR1a via heteroexchange with L-glutamate without direct activation of mGluR1a. Journal of Neurochemistry. 63:1994;2038-2047.
247. Thomsen C., Boel E., Suzdak P.D. Actions of phenylglycine analogs at subtypes of the metabotropic glutamate receptor family. European Journal of Pharmacology - Molecular Pharmacology Section. 267:1994;77-84.
248. Thomsen C., Bruno V., Nicoletti F., Marinozzi M., Pellicciari R. (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors. Molecular Pharmacology. 50:1996;6-9.
249. Thomsen C., Pekhletski R., Haldeman B., Gilbert T.A., O'Hara P., Hampson D.R. Cloning and characterization of a metabotropic glutamate receptor, mGluR4b. Neuropharmacology. 36:1997;21-30.
250. 3H]amino-4-phosphonobutyrate binding in mouse brain. Journal of Neurochemistry. 72:1999;835-840.
251. Thomsen C., Suzdak P.D. Serine-O-phosphate has affinity for type-IV, but not type-I, metabotropic glutamate receptor. NeuroReport. 4:1993;1099-1101.
252. Thoreson W.B., Gottesman J., Jane D.E., Tse H.-W., Watkins J.C., Miller R.F. Two phenylglycine derivatives antagonise responses to L-AP4 in ON bipolar cells of the amphibian retina. Neuropharmacology. 36:1997;13-20.
253. Toms N.J., Jane D.E., Kemp M.C., Bedingfield J.S., Roberts P.J. The effects of (RS)-α-cyclopropyl-4-phosphonophenylglycine ((RS)-CPPG), a potent and selective metabotropic glutamate receptor antagonist. British Journal of Pharmacology. 119:1996;851-854.
254. Tones M.A., Bendali N., Flor P.J., Knöpfel T., Kuhn R. The agonist selectivity of a class III metabotropic glutamate receptor, human mGluR4a, is determined by the N-terminal extracellular domain. Neuroreport. 7:1995;117-120.
255. Tsujishima H., Nakatani K., Shimamoto K., Shigeri Y., Yumoto N., Ohfune Y. Photocycloaddition of α,β-unsaturated-γ-lactam with ethylene. Synthesis of conformationally restricted glutamate analogs, L-2-(2-carboxycyclobutyl)glycines. Tetrahedron Letters. 39:1998;1193-1196.
256. Tückmantel W., Kozikowski A.P., Wang S., Pshenichkin S., Wroblewski J.T. Synthesis, molecular modeling, and biology of the 1-benzyl dervivative of APDC - an apparent mGluR6 selective ligand. Biomedical Chemistry Letters. 7:1997;601-606.
257. Uyama Y., Ishida M., Shinozaki H. DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice. Brain Research. 752:1997;327-330.
258. Valli M.J., Schoepp D.D., Wright R.A., Johnson B.G., Kingston A.E., Tomlinson R., Monn J.A. Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acid. Bioorganic Medical Chemistry Letters. 8:1998;1985-1990.
259. Vandergriff J., Rasmussen K. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coerulus neurons and behavioral signs of morphine withdrawal. Neuropharmacology. 38:1999;217-222.
260. VanWagenen B.C., Artman L.D., Hammerland L.G., Hung B.C.P., Johnston J., Krapcho K., Levinthal C., Logan M.A., Moe S.T., Mueller A.L., Simin R., Smith D.L., Storjohann L., Stormann T.M. In Vitro pharmacological characterizations of NPS 2390: a highly potent and selective, non-competitive antagonist of group I metabotropic glutamate receptors. Society of Neuroscience Abstracts. 24:1998;576.
261. Varney, M.A., Cosford, N., Jachec, C., Rao, S., Sacaan, A., Santori, E., Allgeier, H., Gasparini, F., Flor, P.J., Kuhn, R., Hess, S.D., Veliçelebi, G., Johnson, E.C., 1999. Characterization of SIB-1757 and SIB-1893: highly selective antagonists at metabotropic glutamate receptor subtype 5. British Journal of Pharmacology (in press).
262. Vignes M., Clarke V.R.J., Davies C.H., Chambers A., Jane D.E., Watkins J.C., Collingridge G.L. Pharmacological evidence for an involvement of group II and group III mGluRs in the presynaptic regulation of excitatory synaptic responses in the CA1 region of rat hippocampal slices. Neuropharmacology. 34:1995;973-982.
263. Watson G.B., Monaghan D.T., Lanthorn T.H. Selective activation of oscillatory currents by trans-ACPD in rat brain mRNA-injected Xenopus oocytes and their blockade by NMDA. European Journal of Pharmacology. 179:1990;479-481.
264. Watkins J.C., Krogsgaard-Larsen P., Honore T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends in Pharmacological Science. 11:1990;25-33.
265. Watkins J.C., Collingridge G.L. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. TIPS. 15:1994;333-342.
266. Wermuth C.G., Mann A., Schoenfelder A., Wright R.A., Johnson B.G., Burnett J.P., Mayne N.G., Schoepp D.D. (2S,4S)-2-Amino-4-(4,4-diphenylbut-1-yl)pentane-1,5-dioic acid: A potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase. Journal of Medicinal Chemistry. 39:1996;814-816.
267. Wilsch V.W., Pidoplichko V.I., Opitz T., Shinozaki H., Reymann K.G. Metabotropic glutamate receptor agonist DCG-IV as NMDA receptor agonist in immature rat hippocampal neurons. European Journal of Pharmacology. 262:1994;287-291.
268. Wilson C., Howard J.A.K., Jane D.E., Sunter D.C., Watkins J.C. Absolute configuration of (+)-α-methyl-4-carboxyphenylglycine (MCPG), a metabotropic glutamate receptor antagonist. Acta Crystallogica. C53:1997;909-911.
269. Wroblewska B., Wroblewski J.T., Pshenichkin S., Surin A., Sullivan S.E., Neale J.H. N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. Journal of Neurochemistry. 69:1997;174-181.
270. Wu S., Wright R.A., Rockey P.K., Burgett S.G., Arnold P.R., Johnson B.G., Schoepp D.D., Belagaje R. Group III human metabotropic glutamate receptors 4, 7,